Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955886803> ?p ?o ?g. }
- W2955886803 endingPage "1059" @default.
- W2955886803 startingPage "1059" @default.
- W2955886803 abstract "<h3>Importance</h3> Microcystic adnexal carcinoma (MAC) occurs primarily in older adults of white race/ethnicity on sun-exposed skin of the head and neck. There are no formal guiding principles based on expert review of the evidence to assist clinicians in providing the highest-quality care for patients. <h3>Objective</h3> To develop recommendations for the care of adults with MAC. <h3>Evidence Review</h3> A systematic review of the literature (1990 to June 2018) was performed using MEDLINE, Embase, Web of Science, and the Cochrane Library. The keywords searched were<i>microcystic adnexal carcinoma</i>,<i>sclerosing sweat gland carcinoma</i>,<i>sclerosing sweat duct carcinoma</i>,<i>syringomatous carcinoma</i>,<i>malignant syringoma</i>,<i>sweat gland carcinoma with syringomatous features</i>,<i>locally aggressive adnexal carcinoma</i>, and<i>combined adnexal tumor</i>. A multidisciplinary expert committee critically evaluated the literature to create recommendations for clinical practice. Statistical analysis was used to estimate optimal surgical margins. <h3>Findings</h3> In total, 55 studies met our inclusion criteria. The mean age of 1968 patients across the studies was 61.8 years; 54.1% were women. Recommendations were generated for diagnosis, treatment, and follow-up of MAC. There are 5 key findings of the expert committee based on the available evidence: (1) A suspect skin lesion requires a deep biopsy that includes subcutis. (2) MAC confined to the skin is best treated by surgery that examines the surrounding and deep edges of the tissue removed (Mohs micrographic surgery or complete circumferential peripheral and deep margin assessment). (3) Radiotherapy can be considered as an adjuvant for MAC at high risk for recurrence, surgically unresectable tumors, or patients who cannot have surgery for medical reasons. (4) Patients should be seen by a physician familiar with MAC every 6 to 12 months for the first 5 years after treatment. Patient education on photoprotection, periodic skin self-examination, postoperative healing, and the possible normal changes in local sensation (eg, initial hyperalgesia) should be considered. (5) There is limited evidence to guide the treatment of metastasis in MAC due to its rarity. Limitations of our findings are that the medical literature on MAC comprises only retrospective reviews and descriptions of individual patients and there are no controlled studies to guide management. <h3>Conclusions and Relevance</h3> The presented clinical practice guidelines provide an outline for the diagnosis and management of MAC. Future efforts using multi-institutional registries may improve our understanding of the natural history of the disease in patients with lymph node or nerve involvement, the role of radiotherapy, and the treatment of metastatic MAC with drug therapy." @default.
- W2955886803 created "2019-07-12" @default.
- W2955886803 creator A5000384489 @default.
- W2955886803 creator A5001966491 @default.
- W2955886803 creator A5004643286 @default.
- W2955886803 creator A5004762586 @default.
- W2955886803 creator A5004929115 @default.
- W2955886803 creator A5007444643 @default.
- W2955886803 creator A5007586844 @default.
- W2955886803 creator A5007927145 @default.
- W2955886803 creator A5013038907 @default.
- W2955886803 creator A5014370578 @default.
- W2955886803 creator A5015017942 @default.
- W2955886803 creator A5017093116 @default.
- W2955886803 creator A5018805513 @default.
- W2955886803 creator A5022216826 @default.
- W2955886803 creator A5023226548 @default.
- W2955886803 creator A5023339543 @default.
- W2955886803 creator A5029397040 @default.
- W2955886803 creator A5029957317 @default.
- W2955886803 creator A5031738955 @default.
- W2955886803 creator A5033750345 @default.
- W2955886803 creator A5035539932 @default.
- W2955886803 creator A5036539429 @default.
- W2955886803 creator A5037538628 @default.
- W2955886803 creator A5039210100 @default.
- W2955886803 creator A5040495839 @default.
- W2955886803 creator A5046286542 @default.
- W2955886803 creator A5048000762 @default.
- W2955886803 creator A5048005267 @default.
- W2955886803 creator A5049777565 @default.
- W2955886803 creator A5053127185 @default.
- W2955886803 creator A5054780795 @default.
- W2955886803 creator A5055161116 @default.
- W2955886803 creator A5065354901 @default.
- W2955886803 creator A5068073376 @default.
- W2955886803 creator A5068787930 @default.
- W2955886803 creator A5070429055 @default.
- W2955886803 creator A5073740336 @default.
- W2955886803 creator A5077628272 @default.
- W2955886803 creator A5080377425 @default.
- W2955886803 creator A5080613931 @default.
- W2955886803 creator A5081402333 @default.
- W2955886803 creator A5081442837 @default.
- W2955886803 creator A5084863176 @default.
- W2955886803 creator A5088399398 @default.
- W2955886803 creator A5088843308 @default.
- W2955886803 date "2019-09-01" @default.
- W2955886803 modified "2023-10-16" @default.
- W2955886803 title "Evidence-Based Clinical Practice Guidelines for Microcystic Adnexal Carcinoma" @default.
- W2955886803 cites W1812183306 @default.
- W2955886803 cites W1964307321 @default.
- W2955886803 cites W1982589492 @default.
- W2955886803 cites W1982783557 @default.
- W2955886803 cites W1983103562 @default.
- W2955886803 cites W1984306820 @default.
- W2955886803 cites W1986956358 @default.
- W2955886803 cites W1988185925 @default.
- W2955886803 cites W1989729725 @default.
- W2955886803 cites W1996181793 @default.
- W2955886803 cites W2005723920 @default.
- W2955886803 cites W2007404734 @default.
- W2955886803 cites W2012776578 @default.
- W2955886803 cites W2013745628 @default.
- W2955886803 cites W2028626295 @default.
- W2955886803 cites W2038808538 @default.
- W2955886803 cites W2039928142 @default.
- W2955886803 cites W2041245644 @default.
- W2955886803 cites W2048255688 @default.
- W2955886803 cites W2049419759 @default.
- W2955886803 cites W2055267800 @default.
- W2955886803 cites W2067313017 @default.
- W2955886803 cites W2098339077 @default.
- W2955886803 cites W2111581852 @default.
- W2955886803 cites W2118633570 @default.
- W2955886803 cites W2131230292 @default.
- W2955886803 cites W2149953047 @default.
- W2955886803 cites W2155498141 @default.
- W2955886803 cites W2158232638 @default.
- W2955886803 cites W2164221427 @default.
- W2955886803 cites W2170645257 @default.
- W2955886803 cites W2299580795 @default.
- W2955886803 cites W2323233595 @default.
- W2955886803 cites W2329130478 @default.
- W2955886803 cites W2334885821 @default.
- W2955886803 cites W2338132270 @default.
- W2955886803 cites W2341402733 @default.
- W2955886803 cites W2507647206 @default.
- W2955886803 cites W2521586047 @default.
- W2955886803 cites W2561638262 @default.
- W2955886803 cites W2594439813 @default.
- W2955886803 cites W2608254998 @default.
- W2955886803 cites W2624147378 @default.
- W2955886803 cites W2794353750 @default.
- W2955886803 cites W4231600051 @default.
- W2955886803 cites W4233969596 @default.
- W2955886803 cites W4234534895 @default.
- W2955886803 cites W4234617062 @default.